Alcon Inc. (2U3)
XETR
Closed
Oct 8, 2026
Day's Range
55.5252 wk Range
52.42Overview - 2U3 - Alcon Inc.
Key Statistics
Valuation
Enterprise Value
27.71B
P/E (Trailing)
‪48.37‬
PEG Ratio
‪-0.48‬
Price / Sales (TTM)
‪2.51‬
Price / Book
‪1.42‬
EV / EBITDA
‪12.98‬
Profitability
Gross Margin
‪59.33%‬
Profit Margin
‪5.92%‬
Operating Margin
‪14.63%‬
Return on Assets
‪2.79%‬
Return on Equity
‪2.94%‬
Ownership
Shares Outstanding
483.40M
Float
481.83M
Held by Insiders
‪0.19%‬
Held by Institutions
‪63.56%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪60.31‬
200-Day Avg
‪62.85‬
Dividends
Payout Ratio
‪27.03%‬
Market Cap - 2U3 - Alcon Inc.
Peers - 2U3 - Alcon Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XETR.
- 2U3XETRAlcon Inc.27.36BMarket Cap-15.69%52-week change48.38P/E (Trailing)‪5.92%‬Profit Margin
- IUI1XETRIntuitive Surgical Inc.126.77BMarket Cap-10.60%52-week change45.89P/E (Trailing)‪28.44%‬Profit Margin
- ESLXETREssilorLuxottica65.64BMarket Cap-97.00%52-week change26.75P/E (Trailing)‪8.51%‬Profit Margin
- BOXXETRBecton, Dickinson and Company42.92BMarket Cap-3.55%52-week change30.66P/E (Trailing)‪4.19%‬Profit Margin
- 56S1XETRSartorius Stedim Biotech S.A.20.25BMarket Cap+6.24%52-week change69.17P/E (Trailing)‪9.73%‬Profit Margin
- SRT3XETRSartorius AG Preference Shares17.83BMarket Cap+25.26%52-week change93.75P/E (Trailing)‪5.47%‬Profit Margin
- QS51XETRStraumann Holding AG15.38BMarket Cap+1.53%52-week change39.07P/E (Trailing)‪14.00%‬Profit Margin
Profile Summary - 2U3 - Alcon Inc.
About
Alcon Inc. is a global eye care company focused on products and technologies that support vision health across surgical and everyday care settings. Alcon Inc. develops, manufactures, and markets a broad portfolio for cataract surgery, vitreoretinal procedures, glaucoma care, refractive surgery, contact lenses, lens…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
